Veradigm | MDRX - Los Gastos De Explotación

Precio De Mercado
4.55
Cambio Diario
-0.03 -0.66%
Mensual
1.11%
Anual
4.36%
Q1 Expectativa
4.44




Los Gastos De Explotación Cambio Fecha
Alcidion AUD 23.27M 565K 2025-12
Ambu A/S DKK 1.39B 75M 2025-12
Amplifon EUR 539.04M 16.22M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Centene USD 50.96B 30.01B 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cigna USD 41.71B 92.12M 2025-12
Coloplast 5.19B 185M 2025-12
Computer Programs Systems USD 87.92M 45.53M 2023-09
Convatec Group USD 1B 518M 2024-12
CVS Health USD 103.58B 3.66B 2025-12
Diasorin EUR 224.05M 6.89M 2025-09
Elevance Health USD 49.17B 5.21B 2025-12
General Electric Aerospace USD 10.94B 7.87B 2025-12
Gulf Medical Proj AED 182.97M 16.46M 2025-12
Humana USD 33.32B 1.07B 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Maximus USD 1.72B 524.26M 2025-12
McKesson USD 104.5B 2.85B 2025-12
Med Life RON 747.87M 6.92M 2025-09
Molina Healthcare USD 11.53B 191M 2025-12
Omnicell USD 312.8M 13.16M 2025-12
Oriola-kd EUR 496.6M 39.9M 2025-12
Owens Minor USD 708.15M 1.14B 2025-12
Quest Diagnostics USD 2.42B 4.84B 2025-12
Rede D'or Sao Luiz BRL 11.81B 129.96M 2025-12
Siemens Healthineers EUR 4.73B 706M 2025-12
Sonova Holding CHF 1.52B 59.9M 2025-12
Supermax Corporation Bhd MYR 250.99M 97.72M 2025-12
UnitedHealth USD 109.96B 1.11B 2025-12
Veeva Systems USD 590.07M 19.69M 2025-12
Veradigm USD 188M 61.08M 2022-12
Xerox USD 365M 1.18B 2025-09